Latest News & Updates

Breaking News

  • 8 hours ago

  • Pharma Now Editorial Team

Dr. Reddy's Gains Health Canada Approval for Generic Semaglutide, First to Market in Canada
Breaking News
Regeneron Phase 3 Fianlimab Combination Misses Primary PFS Endpoint in First-Line Metastatic Melanoma

Pharma Now Editorial Team

Other trending news you may like to read

Dr. Reddy's Gains Health Canada Approval for Generic Semaglutide, First to Market in Canada

Dr. Reddy's becomes the first company to receive Health Canada approval for generic semaglutide injection, ahead of all competing generics manufacturers.

Pharma Now Editorial Team

Pharma Now

Regeneron Phase 3 Fianlimab Combination Misses Primary PFS Endpoint in First-Line Metastatic Melanoma

Regeneron's Phase 3 fianlimab-cemiplimab trial misses PFS significance vs. pembrolizumab, prompting manufacturing and pipeline reassessment.

Pharma Now Editorial Team

Pharma Now

FDA Warns Against Use of Expired Amazon Basic Care Levonorgestrel 1.5 mg Across Multiple Lots

FDA flags multiple Amazon Basic Care levonorgestrel 1.5 mg lots delivered past expiration, raising distributor oversight and expiry control concerns.

Pharma Now Editorial Team

Pharma Now

GSK Secures Updated FDA Approval Letter for TWINRIX Combination Hepatitis Vaccine in May 2026

FDA issues a May 2026 approval letter for GSK's TWINRIX, continuing a documented post-approval supplement cycle for the combination hepatitis vaccine.

Pharma Now Editorial Team

Pharma Now